MIRM vs TOST · rev $336.1M vs P/E 161, rev $3.54B
Mirum Pharmaceuticals Inc (MIRM) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
MIRM currently screens at market cap $6.22B. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the MIRM and TOST stock pages for the full models.
Not investment advice.